Basilea Pharmaceutica (XSWX:BSLN) YoY EPS Growth : -187.32% (As of Dec. 2023)

View and export this data going back to 2004. Start your Free Trial

What is Basilea Pharmaceutica YoY EPS Growth?

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. Basilea Pharmaceutica's YoY EPS Growth for the quarter that ended in Dec. 2023 was -187.32%.

Basilea Pharmaceutica's Earnings per Share (Diluted) for the six months ended in Dec. 2023 was CHF-1.79.

Basilea Pharmaceutica YoY EPS Growth Historical Data

The historical data trend for Basilea Pharmaceutica's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Basilea Pharmaceutica YoY EPS Growth Chart

Basilea Pharmaceutica Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

YoY EPS Growth

Get a 7-Day Free Trial

28.03

31.25

59.44

275.86

-15.69

Basilea Pharmaceutica Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
YoY EPS Growth	Get a 7-Day Free Trial															153.62	44.02	62.70	334.95	-187.32

Basilea Pharmaceutica YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

Basilea Pharmaceutica's YoY EPS Growth for the fiscal year that ended in Dec. 2023 is calculated as:

	YoY EPS Growth (A: Dec. 2023 )
=	(Earnings per Share (Diluted) (A: Dec. 2023 )	-	Earnings per Share (Diluted) (A: Dec. 2022 ))	/	\| Earnings per Share (Diluted) (A: Dec. 2022 ) \|
=	(0.86	-	1.02)	/	\| 1.02 \|
=	-15.69 %

Basilea Pharmaceutica's YoY EPS Growth for the quarter that ended in Dec. 2023 is calculated as:

	YoY EPS Growth (Q: Dec. 2023 )
=	(Earnings per Share (Diluted) (Q: Dec. 2023 )	-	Earnings per Share (Diluted) (Q: Dec. 2022 ))	/	\| Earnings per Share (Diluted) (Q: Dec. 2022 )) \|
=	(-1.79	-	2.05)	/	\| 2.05 \|
=	-187.32 %

Basilea Pharmaceutica YoY EPS Growth Related Terms

Thank you for viewing the detailed overview of Basilea Pharmaceutica's YoY EPS Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Basilea Pharmaceutica (XSWX:BSLN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Basilea Pharmaceutica Ltd (XSWX:BSLN) » Definitions » YoY EPS Growth

Comparable Companies

Traded in Other Exchanges

BSLNz:UK

Address

Switzerland Innovation Park, Basel Area, Main Campus, Near Basel, Allschwil, CHE, 4058

Website

https://www.basilea.com

Basilea Pharmaceutica Ltd is a commercial-stage biopharmaceutical company committed to discovering, developing and commercializing drugs to meet the needs of patients with severe bacterial and fungal infections. The Company has operating subsidiaries in the United Kingdom and Germany. Geographically company derives revenue from Japan, Ireland, Republic of Korea, USA, Uruguay, Sweden, Canada, Jordan, Switzerland and Other countries.

Basilea Pharmaceutica (XSWX:BSLN) Headlines

No Headlines